Government of India under the dynamic leadership of our worthy Prime Minister Shri Narender Modi is promoting MAKE IN INDIA concept. The Pharmaceutical industry in India is the 3rd largest in the world in terms of volume and 14th largest in terms of value. The Pharma sector currently contributes to around 1.72% of the country’s GDP. Pharma Industry in India is of more than 50 lakh crore. The prices of raw materials, known as active pharmaceutical ingredients (APIs) or bulk drugs, have grown multifold since November-20. The raw material of maximum no of medicine is imported from China & India has to import no. of salts from China. So in this way our foreign currency is going to China. Indian Govt is promoting A.P.I.(ACTIVE PHARMACEAUTICAL INGREDIENTS) salt in India under the banner of MAKE IN INDIA. India is 3rd largest market for APIs globally, 8% share in the Global API Industry, 500+ different APIs are manufactured in India and it contributes 57% of APIs to prequalified list of the WHO. Now, as India seeks self-dependence in API production, experts believe China, the largest API manufacturer, is responding with price fluctuation. In order to that under